The Desmond Tutu HIV Centre, Institute for Infectious Disease and Molecular Medicine, and the Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
PLoS One. 2013;8(3):e57907. doi: 10.1371/journal.pone.0057907. Epub 2013 Mar 5.
To determine the proportion, characteristics and outcomes of patients who transfer-out from an antiretroviral therapy (ART) service in a South African township.
This retrospective cohort study included all patients aged ≥15 years who enrolled between September 2002 and December 2009. Follow-up data were censored in December 2010. Kaplan-Meier survival analysis was used to describe time to transfer-out and cox proportional hazard analysis was used to determine associated risk factors.
4511 patients (4003 ART-naïve and 508 non-naïve at baseline) received ART during the study period. Overall, 597 (13.2%) transferred out. The probability of transferring out by one year of ART steadily increased from 1.4% in 2002/2004 cohort to 8.9% for the 2009 cohort. Independent risk factors for transfer-out were more recent calendar year of enrolment, younger age (≤25 years) and being ART non-naïve at baseline (i.e., having previously transferred into this clinic from another facility). The proportions of patients transferred out who had a CD4 cell count <200 cells/µL and/or a viral load ≥1000 copies/mL were 19% and 20%, respectively.
With scale-up of ART over time, an increasing proportion of patients are transferring between ART services and information systems are needed to track patients. Approximately one-fifth of these have viral loads >1000 copies/mL around the time of transfer, suggesting the need for careful adherence counseling and assessment of medication supplies among those planning transfer.
确定南非一个城镇的抗逆转录病毒疗法(ART)服务中转出患者的比例、特征和结局。
本回顾性队列研究纳入了 2002 年 9 月至 2009 年 12 月期间登记的所有年龄≥15 岁的患者。随访数据于 2010 年 12 月截止。Kaplan-Meier 生存分析用于描述转出时间,Cox 比例风险分析用于确定相关的危险因素。
研究期间,4511 例患者(4003 例为 ART 初治患者,508 例为基线时非初治患者)接受了 ART。总体上,有 597 例(13.2%)转出。接受 ART 治疗一年后,转出的概率从 2002/2004 队列的 1.4%稳步上升至 2009 队列的 8.9%。转出的独立危险因素包括较近的登记年份、较年轻(≤25 岁)和基线时 ART 非初治(即,从其他机构转入本诊所)。转出患者中 CD4 细胞计数<200 个/µL 和/或病毒载量≥1000 拷贝/mL 的比例分别为 19%和 20%。
随着 ART 的普及,越来越多的患者在 ART 服务之间转移,需要信息系统来跟踪患者。这些患者中约有五分之一在转移时的病毒载量>1000 拷贝/mL,这表明需要在计划转移的患者中进行仔细的依从性咨询和药物供应评估。